🟢 BeyondSpring is trading 21.08% up today with no fresh company-specific catalyst identified

BeyondSpring is trading at $0.56, up 21.08%, with available evidence pointing to sector context rather than a confirmed company-specific catalyst.

• The biotech sector is up 2.18%, a possible supportive backdrop that does not establish the cause of BeyondSpring’s larger gain.
• No fresh BeyondSpring-specific announcement explaining the October 28 move has been identified; the latest listed company news is the earlier FDA Fast Track and DUBLIN-4 update.